Dr Mark Thaller PhD

Mark Thaller

Institute of Metabolism and Systems Research
Honorary Senior Clinical Research Fellow

Contact details

College of Medical and Dental Sciences
University of Birmingham
B15 2TT

Dr Mark Thaller is an Honorary Senior Clinical Research Fellow He is also a Neurology Registrar in the West Midlands. He is currently doing an MD under the supervision of Professor Sinclair, on the ovarian phenotype and adipose androgens in Idiopathic Intracranial Hypertension. He is also actively working on further studies within the group including Clinical Trials.


  • MRCP 2017
  • MBBCh 2012


Mark is currently working on his MD within the University of Birmingham with Professor Sinclair. He has been a West Midlands Neurology Registrar since 2017 and is planning on pursuing his specialist interest in headache management. He is working within the IIH and Headache Services as well as on current clinical trials.


Mark’s research aims to improve the evidence base in Idiopathic Intracranial Hypertension (IIH). An aspect is to establish the role of adipose tissue for the androgen excess seen in IIH as a potential driver and affecting lipid metabolism. As part of this, he is currently running some of the sub studies of the IIH Pressure trial.

His other research area is into determining whether there is an ovarian phenotype affecting fertility within IIH and this includes using the IIH:Life Database developed by the Birmingham team.


Thaller M, Tsermoulas G, Sun R, Mollan SP and Sinclair AJ. Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. Journal of Neurology, Neurosurgery & Psychiatry. [Epub ahead of print: 24 Dec 2020.] doi: 10.1136/jnnp-2020-325519.

Sawlani V, Scotton S, Nader K, Jen JP, Patel M, Gokani K, Denno P, Thaller M, Englezou C, Janjua U, Bowen M, Hoskote C, Veenith T, Hassan-Smith G, Jacob S. COVID-19-related intracranial imaging findings: a large single-centre experience. Clin Radiol. 2021 Feb;76(2):108-116. doi: 10.1016/j.crad.2020.09.002. [Epub ahead of print: 15 Sep 2020].

Thaller M and Mitchell N. mSOAR: An effective bedside stroke prognosis tool. Clinical Medicine. 2017;17(3): 204–208. PMID: 28572220.

Thaller M, Hyland ME, Kandasamy R and Sadler M. Is patient acceptance of the diagnosis of psychogenic nonepileptic seizures linked to symptomatology? Journal of Clinical and Experimental Neuropsychology. 2016;38(3):338-40. PMID: 26646739.

Thaller M and Hughes T. Inter-rater agreement of observable and elicitable neurological signs. Clinical Medicine. June 2014;14(3):264-7 PMID: 24889570.